Results 61 to 70 of about 34,041 (224)

Impact of Nirsevimab on Respiratory Syncytial Virus PCR Test Positivity in Young Infants: A Community‐Level Observational Study in Queensland, Australia

Journal of Paediatrics and Child Health, Volume 62, Issue 4, Page 614-620, April 2026.
ABSTRACT Aim In April 2024 nirsevimab, a long‐acting respiratory syncytial virus (RSV)‐specific monoclonal antibody, was made available free of charge to all newborn infants in Queensland. We aimed to explore the community‐level impact of a nirsevimab‐based prevention program on RSV detection percentages among infants aged ≤ 3 months in Queensland ...
Asmaa El‐Heneidy, Keith Grimwood, Jennifer M. Robson, Chanpaseuth Vicki Vilaylath, Sarah G. Cherian, Stephen B. Lambert, Robert S. Ware   +6 more
wiley   +1 more source

Bordetella pertussis, Finland and France [PDF]

, 2006
We used pulsed-field gel electrophoresis analysis and genotyping to compare clinical isolates of Bordetella pertussis recovered since the early 1990s in Finland and France, 2 countries with similar histories of long-term mass vaccination with whole-cell ...
Guiso, Nicole, Annika Elomaa, He, Qiushui, Nicole Guiso, Caro, Valérie, Elomaa, Annika, Qiushui He, Jussi Mertsola, Mertsola, Jussi, Delphine Brun, Brun, Delphine, Valérie Caro   +11 more
core   +1 more source

Perspectives on Pertussis Prevention

Acta Paediatrica, EarlyView.
Ulrich Heininger
wiley   +1 more source

Hypercapnia as a Key Mechanism in the Development of Pulmonary Hypertension in Malignant Pertussis: A Case Report

Respirology Case Reports, Volume 14, Issue 3, March 2026.
Despite intensive care advances, malignant pertussis (MP) remains highly lethal. Our case suggests that hypercapnia‐induced pulmonary vasoconstriction may play a reversible role in MP pathophysiology. Thus, targeting hypercapnia control could represent a promising therapeutic approach in managing this severe complication.
Juan Ignacio Muñoz‐Bonet, Francisco José Sebastián‐Cuevas, Eva María Flor‐Macián, María del Carmen Ortega‐Sánchez, Andrés Rodríguez‐Sacristán, Juan Brines   +5 more
wiley   +1 more source

Positivity analysis of Bordetella spp. and SARS-CoV-2 coinfections in clinical samples from Colombia, 2021–2022

Microbiology Spectrum
Pertussis and COVID-19 are respiratory diseases with similar clinical manifestations, complicating diagnosis. In Colombia, pertussis surveillance is based on probable cases confirmed through laboratory detection of Bordetella pertussis.
Valentina Bonilla-Bravo, Efrain Montilla-Escudero, Ximena Castro Martinez, Fabiola Rojas, Carolina Duarte, Sandra Aparicio, Sergio Yebrail Gómez-Rangel, Paula Rodriguez Romero, Sandra Lucero Bonilla, Franklyn Prieto Alvarado, Jaid Rojas Sotelo, Gloria Rey Benito   +11 more
doaj   +1 more source

Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis. [PDF]

PLoS ONE, 2011
BACKGROUND: Bordetella pertussis is the primary etiologic agent of the disease pertussis. Universal immunization programs have contributed to a significant reduction in morbidity and mortality of pertussis; however, incidence of the disease, especially ...
Hyun-Ja Han, Asaomi Kuwae, Akio Abe, Yoshichika Arakawa, Kazunari Kamachi   +4 more
doaj   +1 more source

Bordetella pertussis Polymorphism and Pertussis Vaccines [PDF]

Clinical and Vaccine Immunology, 2008
The topic of the article by Bottero et al. (1) is an important one, a bacterial vaccine for a preventable disease, pertussis. Many articles have been published on the subject in the last 10 years (for a review, see reference 6). In their study, Bottero et al.
openaire   +2 more sources

Torque Teno Virus Levels During Viral Respiratory Infections: The Interplay With Immune Dysregulation and Coagulopathy Biomarkers

Journal of Medical Virology, Volume 98, Issue 2, February 2026.
ABSTRACT Torque teno virus (TTV) is a ubiquitous, nonenveloped DNA virus of the Anelloviridae family and a proposed surrogate marker of immune competence. Although nonpathogenic, its replication reflects host immune status and is associated with immune dysregulation during respiratory viral infections (RVIs).
Roberto Ferrarese, Pietro Giorgio Spezia, Sara Boutahar, Angelo Paolo Genoni, Gabriele Arcari, Gaia Zambon, Maria Dolci, Sara D'alessandro, Giuseppe Sberna, Serena Delbue, Nicasio Mancini, Fabrizio Maggi, Lucia Signorini, Federica Novazzi   +13 more
wiley   +1 more source

Bordetella BcrH1 and BcrH2 Are Specific Chaperones for the Pore‐Forming Complex

Microbiology and Immunology, Volume 70, Issue 2, Page 57-67, February 2026.
ABSTRACT Bordetella has a type III secretion system that secretes virulence proteins crucial to the establishment of infection. The genes encoding components of the Bordetella type III secretion system are located in the bsc region on the chromosome. This region includes the bcrH1 and bcrH2 genes, which respectively encode the proteins BcrH1 and BcrH2.
Yuya Kishino, Toshinobu Ogawa, Hiroko Sato, Akio Abe, Asaomi Kuwae   +4 more
wiley   +1 more source

Low Bordetella pertussis Antibody Seroprevalence Among Mothers and Infants

, 2020
Objective: The greatest risk of morbidity and mortality from pertussis infection is observed among infants who are 6 months and younger. Therefore protection from pertussis infection is very important during the first 6 months of life.

core   +1 more source